APOE and Alzheimer disease: We will utilize the information available at the local biobank, and the relatively high prevalence of APOE ε4/ε4 homozygotes in the Finnish population to recruit three groups (matched at group-level for age and sex) with different APOE genotype, and thus different genetic risk for future sporadic AD.